08:56 AM EDT, 05/21/2025 (MT Newswires) -- Conduit Pharmaceuticals ( CDT ) said Wednesday it has regained compliance with Nasdaq's minimum bid price and stockholders' equity requirements, citing a notification from the stock exchange.

The biopharmaceutical company said Nasdaq's hearing panel has implemented a one-year Discretionary Panel Monitor starting May 15 to ensure long-term compliance.

Shares of the company were more than 3% higher in recent premarket activity.